Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer.
about
Pulmonary metastasectomy: a common practice based on weak evidenceColorectal cancer: Metastases to a single organOligometastasis and oligo-recurrence: more than a miragePulmonary metastasectomy for colorectal cancer: how many nodules, how many times?Stereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancerSurvival after initial lung metastasectomy for metastatic colorectal cancer in the modern chemotherapeutic eraInteraction of tumour biology and tumour burden in determining outcome after hepatic resection for colorectal metastases.Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases.Descriptive analysis of and overall survival after surgical treatment of lung metastases.Oncological outcome of unresectable lung metastases without extrapulmonary metastases in colorectal cancer.Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach.Peri-operative chemotherapy in the management of resectable colorectal cancer pulmonary metastases.Factors affecting the outcome of a pulmonary resection for metastatic colorectal cancer: efficacy and pitfalls.The prognostic importance of the number of metastases in pulmonary metastasectomy of colorectal cancer.Nomograms for colorectal cancer: A systematic reviewThe impact of pulmonary metastasectomy in patients with previously resected colorectal cancer liver metastasesHypofractionated radiotherapy for primary or secondary oligometastatic lung cancer using Tomotherapy.Colorectal liver metastases: current and future perspectives.Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach.Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach.Preoperative combined hemoglobin, albumin, lymphocyte and platelet levels predict survival in patients with locally advanced colorectal cancer.Prognostic scores for colorectal liver metastasis: clinically important or an academic exercise?Colorectal cancer and thoracic surgeons: close encounters of the third kind.Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis.Stereotactic body radiotherapy for oligometastases confined to the para-aortic region: clinical outcomes and the significance of radiotherapy field and dose.High dose stereotactic body radiotherapy using three fractions for colorectal oligometastases.Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes.Management of resectable colorectal lung metastases.Are there recognized prognostic factors for patients undergoing pulmonary metastasectomy for colorectal carcinoma?Evaluation of carcinoembryonic antigen (CEA) density as a prognostic factor for percutaneous ablation of pulmonary colorectal metastases.Resection of non-hepatic colorectal cancer metastasisAdjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancerGuidelines for resection of colorectal cancer liver metastases.Is the mediastinal lymphadenectomy during pulmonary metastasectomy of colorectal cancer necessary?Growth rate of chemotherapy-naïve lung metastasis from colorectal cancer could be a predictor of early relapse after lung resection.Role of 18F-FDG PET/CT vs CT-scan in patients with pulmonary metastases previously operated on for colorectal liver metastases.Clinical significance of systemic chemotherapy after curative resection of metachronous pulmonary metastases from colorectal cancer.Pulmonary metastasectomy in colorectal cancer: a systematic review and quantitative synthesis.Usefulness of Inflammation-Based Prognostic Score in Patients Undergoing Lung Metastasectomy for Colorectal Carcinoma.[Surgery for metastases, anatomical and ethical limits. Special aspect: oligometastases].
P2860
Q24673666-EC733253-B48B-496D-BFF3-083F253C9A8CQ26778009-A9E576C8-8A2E-4B92-A07F-19483D3BA899Q26828767-D068EAA0-4AA8-4F34-B375-A64556BD66F0Q26859632-5BE4A2E4-4BE9-4A20-B016-F391B2D7CA55Q26866335-08216BDB-D2DB-412C-9B7B-35C846C69324Q33655018-D781B482-B144-435D-9B5C-7B05D7AD8ABDQ33679628-DF8E2714-4BBA-4711-B1C7-53A49EA035E4Q33823590-FE05C5BE-515D-48AC-8FA0-8B07B178E576Q33824311-7C74F0E0-C5CB-4517-A5CC-22AC4F03C58CQ33978181-3E53F756-B4E6-40E3-AD6F-54B5E205D955Q34196471-EE8DF3BC-F40D-4F6F-931C-7376C678232BQ34360237-51702A4B-4F2B-4609-9D80-97E4D4D10971Q34385344-9627947F-8349-43CC-9F9E-307179C85689Q35910767-81FBA08E-A57D-41A1-96B1-2058A50924E0Q36245607-4909E3CF-8CE6-4198-A625-C6A3B020F464Q36318279-1A2CCC4F-34D8-43F2-A27A-12A126E3208FQ36555940-BADDEAF6-6EF2-48BA-B6E0-8F0E225E833FQ36572540-006F38C3-119D-4B69-A1CB-5F25C07D1B76Q37187233-320272C3-2555-404B-96A4-861CA43C78B2Q37445971-1F02B7D3-4C8B-423E-A4FE-09AF21F1AEA7Q37687778-5A18F843-7719-468C-9F1F-B6AB286BD2F0Q37768890-BAC3A5CA-38BB-48C4-A74E-25C60B2E84E4Q38002471-80758AD4-2927-4499-90DA-5E1B978B3B39Q38056097-63DB84CE-2F1A-44BA-88DB-5D32115FD217Q38427413-4BD338FE-11CA-4A63-9FEE-7E7ED2754764Q38465908-2B4E3FA6-270F-4AAF-AAFE-1DA230875203Q38647041-966628E6-AD57-4C36-957E-4CB11E04E3A6Q38667176-E034294B-DC46-4FFE-A9DF-56450A0FD81AQ38940022-5311DF4C-F2CC-40A1-9D9E-C2422B91B374Q40761143-5C6D29AA-7019-40F3-AC0C-6E3090C924E9Q41852206-B8F5517C-1D7C-4223-A6BD-CACBE8FF6F40Q42059647-30606B9C-DCC5-4B25-B42B-5D74F0487AC2Q42150472-460AED19-2D55-4DFB-842B-555634808627Q44213080-3DA52BB4-C893-4945-92B6-6C6120BEC9B4Q48145612-16DC7F30-CAB6-4A28-9710-BC115F86D80EQ50072673-94EEDE98-472E-40EA-B8B3-D41D42013859Q50594005-381A1849-5B92-4BC5-A09D-4F8F56122A2BQ51725271-334BE67F-ECD0-4FBC-B796-E4B2747656B0Q53166483-933E8063-46A8-47A4-907E-60AAED5B3797Q53180522-4F5F556E-D59E-46F6-8AE9-6EAD7A9F398A
P2860
Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Preoperative probability model ...... stases from colorectal cancer.
@en
Preoperative probability model ...... stases from colorectal cancer.
@nl
type
label
Preoperative probability model ...... stases from colorectal cancer.
@en
Preoperative probability model ...... stases from colorectal cancer.
@nl
prefLabel
Preoperative probability model ...... stases from colorectal cancer.
@en
Preoperative probability model ...... stases from colorectal cancer.
@nl
P2093
P356
P1476
Preoperative probability model ...... stases from colorectal cancer.
@en
P2093
P304
P356
10.1002/BJS.4370
P407
P577
2004-01-01T00:00:00Z